CBD’s potential impact on Parkinson’s disease: An updated overview

Abstract

Parkinson’s disease (PD) is primarily known as a motor disorder; however, its debilitating non-motor symptoms have a significant impact on patients’ quality of life. The current standard treatment, l-DOPA, is used to relieve motor symptoms, but prolonged use is often associated with severe side effects. This creates an urgent need for effective alternatives targeting both motor and non-motor symptoms.

Keywords

• cannabidiol
• parkinson’s disease
• l-dopa-induced dyskinesia
• non-motor symptoms
• clinical trials